◂ Announcements

Sep 11, 2017PARTNERSHIPItaly

Sanofi partners with Axxam for CNS drug optimization

Sanofi will work with Axxam, an Italian contract research organization, to optimize small molecules targeting central nervous system diseases.

Status

Announced

Productssmall molecules for CNS diseases

CompaniesSanofi Axxam partner

Sectors#Medical Devices

“Sanofi will work with Axxam, an Italian contract research organization, to optimize small molecules targeting a range of central nervous system diseases.”cen.acs.org

1 source
cen.acs.orgBusiness RoundupSep 11, 2017

Summarized from public sources; check the original articles before acting on it.

More from Sanofi

profile ▸

Apr 14, 2023PARTNERSHIP
Sanofi and Haleon join PA and PulPac's Bottle Collective fiber bottle initiative
PulPac partner PA Consulting partner paconsulting.com
Jan 20, 2020EXPANSIONOrlov Region, Russia, Russia
Sanofi to expand insulin production at Orlov Region plant in Russia
Sanofi russiabusinesstoday.com
Dec 2, 2019ACQUISITIONUnited States$350.0M
Baxter to acquire Seprafilm adhesion barrier from Sanofi for $350M
Sanofi target Baxter International acquirer massdevice.com business-news-today.com
Jun 27, 2018PARTNERSHIP
Sensile Medical partners with Verily and Sanofi to develop connected insulin patch pump
Sanofi partner Sensile Medical partner drugdeliverybusiness.com
Apr 12, 2018INVESTMENTToronto, Ontario, Canada
Sanofi to announce significant investment in Canadian vaccine facility
Sanofi Sanofi Pasteur partner sanoficanada.mediaroom.com
Apr 1, 2018NEW FACILITYNorth York, Ontario, Canada$500.0M1,250 jobsops 2022
Sanofi opens $500M vaccine facility in North York, Ontario
Sanofi financialpost.com pharmaceutical-technology.com

Loading…

Sanofi partners with Axxam for CNS drug optimization · Endata